AIMS/HYPOTHESIS: Rotavirus infection in at-risk children correlates with production of serum autoantibodies indicative of type 1 diabetes progression. Oral infection with rhesus monkey rotavirus (RRV) accelerates diabetes onset in mice. This relates to their rotavirus-specific serum antibody titre and local pro-inflammatory cytokine induction without pancreatic infection. Our aim was to further investigate the roles of serum antibodies and viral extra-intestinal spread in diabetes acceleration by rotavirus. METHODS: Rotavirus-specific serum antibody production was detected by ELISA in diabetes-prone mice given either inactivated or low-dose RRV, in relation to their diabetes development. Serum anti-rotavirus antibody titres and infectious virus in lymph nodes were measured in mice given RRV or porcine rotavirus CRW-8. In lymph node cells, rotavirus antigen presence and immune activation were determined by flow cytometry, in conjunction with cytokine mRNA levels. RESULTS: Acceleration of diabetes by RRV required virus replication, which correlated with antibody presence. CRW-8 induced similar specific total immunoglobulin and IgA titres to those induced by RRV, but did not accelerate diabetes. RRV alone elicited specific serum IgG antibodies with a T helper (Th)1 bias, spread to regional lymph nodes and activated antigen-presenting cells at these sites. RRV increased Th1-specific cytokine expression in pancreatic lymph nodes. Diabetes onset was more rapid in the RRV-infected mice with the greater Th1 bias. CONCLUSIONS/ INTERPRETATION: Acceleration of murine diabetes by rotavirus is virus strain-specific and associated with virus spread to regional lymph nodes, activation of antigen-presenting cells at these sites and induction of a Th1-dominated antibody and cytokine response.
AIMS/HYPOTHESIS: Rotavirus infection in at-risk children correlates with production of serum autoantibodies indicative of type 1 diabetes progression. Oral infection with rhesus monkey rotavirus (RRV) accelerates diabetes onset in mice. This relates to their rotavirus-specific serum antibody titre and local pro-inflammatory cytokine induction without pancreatic infection. Our aim was to further investigate the roles of serum antibodies and viral extra-intestinal spread in diabetes acceleration by rotavirus. METHODS: Rotavirus-specific serum antibody production was detected by ELISA in diabetes-prone mice given either inactivated or low-dose RRV, in relation to their diabetes development. Serum anti-rotavirus antibody titres and infectious virus in lymph nodes were measured in mice given RRV or porcine rotavirus CRW-8. In lymph node cells, rotavirus antigen presence and immune activation were determined by flow cytometry, in conjunction with cytokine mRNA levels. RESULTS: Acceleration of diabetes by RRV required virus replication, which correlated with antibody presence. CRW-8 induced similar specific total immunoglobulin and IgA titres to those induced by RRV, but did not accelerate diabetes. RRV alone elicited specific serum IgG antibodies with a T helper (Th)1 bias, spread to regional lymph nodes and activated antigen-presenting cells at these sites. RRV increased Th1-specific cytokine expression in pancreatic lymph nodes. Diabetes onset was more rapid in the RRV-infected mice with the greater Th1 bias. CONCLUSIONS/ INTERPRETATION: Acceleration of murinediabetes by rotavirus is virus strain-specific and associated with virus spread to regional lymph nodes, activation of antigen-presenting cells at these sites and induction of a Th1-dominated antibody and cytokine response.
Authors: Miia Mäkelä; Outi Vaarala; Robert Hermann; Kimmo Salminen; Tero Vahlberg; Riitta Veijola; Heikki Hyöty; Mikael Knip; Olli Simell; Jorma Ilonen Journal: J Autoimmun Date: 2006-06-06 Impact factor: 7.094
Authors: J Lempainen; S Tauriainen; O Vaarala; M Mäkelä; H Honkanen; J Marttila; R Veijola; O Simell; H Hyöty; M Knip; J Ilonen Journal: Diabetes Metab Res Rev Date: 2012-02 Impact factor: 4.876
Authors: M Lönnrot; K Korpela; M Knip; J Ilonen; O Simell; S Korhonen; K Savola; P Muona; T Simell; P Koskela; H Hyöty Journal: Diabetes Date: 2000-08 Impact factor: 9.461
Authors: B S Coulson; K Grimwood; P J Masendycz; J S Lund; N Mermelstein; R F Bishop; G L Barnes Journal: J Clin Microbiol Date: 1990-06 Impact factor: 5.948
Authors: Kate L Graham; Natalie Sanders; Yan Tan; Janette Allison; Thomas W H Kay; Barbara S Coulson Journal: J Virol Date: 2008-04-16 Impact factor: 5.103
Authors: Margo C Honeyman; David Laine; Yifan Zhan; Sarah Londrigan; Carl Kirkwood; Leonard C Harrison Journal: PLoS One Date: 2014-09-02 Impact factor: 3.240
Authors: Jessica A Pane; Fiona E Fleming; Kate L Graham; Helen E Thomas; Thomas W H Kay; Barbara S Coulson Journal: Sci Rep Date: 2016-07-13 Impact factor: 4.379